Mas17

Mas17

Mas17

But17 is a potent synthetic peptide inhibitor specifically designed to target and inhibit the interaction between the chaperone protein 14-3-3 and its client proteins. This high-purity, research-grade compound serves as a crucial tool molecule in molecular biology and drug discovery, enabling the precise dissection of disease-related signaling pathways where 14-3-3 protein complexes play a central regulatory role.



TECHNICAL SPECIFICATIONS


Item
Specification
Product Name
Mas17
CAS NO.
/
Appearance
White to off-white lyophilized powder
Molecular Formula
C70H132N20O15
Molecular Weight
 1493.96g/mol 
Purity (RP-HPLC)
≥ 95.0%
Solubility

Soluble in water, 0.1 M acetic acid, or DMSO at ≥ 1 mg/mL concentration

Endotoxin< 1.0 EU/mg
Biological Activity
Potent agonist of the Mas receptor; activates downstream signaling pathways
Storage Conditions
Store long-term at -20°C to -80°C; avoid repeated freeze-thaw cycles.
Stock Location
Stock in USA
MOQ
1g


1.MECHANISM OF ACTION

But17 functions by competitively binding to the amphipathic groove of 14-3-3 proteins. This binding effectively disrupts the formation of functional 14-3-3/client protein complexes. By preventing this critical protein-protein interaction (PPI), But17 modulates downstream signaling cascades, leading to altered cellular processes such as apoptosis, cell cycle progression, and metabolism, which are often dysregulated in diseases like cancer and neurodegeneration.


2.PRODUCT INDICATIONS

This product is indicated for in vitro and cellular research applications. Key uses include: studying the biological functions of 14-3-3 proteins, validating 14-3-3/client interactions as therapeutic targets, screening for downstream effects in oncology and neurology research, and serving as a positive control in assays designed to identify novel 14-3-3 inhibitors.


3.CLINICAL EFFICACY OF PRODUCT

But17 is a preclinical research tool and is not used in clinical therapy. However, its demonstrated efficacy in disrupting specific 14-3-3 interactions in experimental models validates the 14-3-3 interface as a druggable target. Research utilizing But17 has provided critical proof-of-concept evidence, supporting the development of novel therapeutic strategies aimed at modulating PPIs for conditions like cancer, where 14-3-3 proteins are often overexpressed and contribute to pathogenesis.


4.DELIVERY & SHIPPING

We specialize in global logistics for various cosmetic peptides. Your order will be handled with the utmost care, ensuring safe, reliable, and intact delivery.
Professional and Secure Packaging
Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation.
We can also customize packaging according to customer needs.
Shipping Methods 
Main Method: International Air Freight

We primarily use DHL, FedEx, UPS, and TNT because of their global reliability, speed, and advanced tracking systems. Air freight ensures the fastest transit time and minimizes the impact of environmental factors on the product.

Premium API Oxandrolone Ucinky Manufacturing
May 25, 26
Premium API Oxandrolone Ucinky Manufacturing
Premium API Oxandrolone Ucinky Manufacturing Leading global supplier of high-purity chemical raw materials for pharmaceutical grade Oxandrolone Ucinky, combining precision engineering with industrial scale. 5000 kg Annual Output 120 Countries Served 5 Days Sample Lead Time 99.7 On-Time Delivery Industrial Precision Pure Chemical Synthesis Engineering the future of pharmaceutical intermediates with unmatched stability. Our facility stands as a global leader in the oxandrolone ucinky sector, utilizing CRYOGENIC CRYSTALLIZATION and advanced chromatography to ensure an assay purity exceeding 99.8. We integrate a fully automated closed-loop system that eliminates human error and contamination.
Clinical Benefits and Applications of Oxandrolone Therapy
May 22, 26
Clinical Benefits and Applications of Oxandrolone Therapy
Oxandrolone therapy represents a sophisticated intersection of endocrine science and regenerative medicine, primarily utilized to address muscle wasting and metabolic dysfunction. In the global pharmaceutical landscape, this specific approach to androgen therapy is valued for its unique ability to promote protein synthesis while exhibiting a lower androgenic profile compared to traditional steroids, making it a critical tool for patients recovering from severe trauma or chronic illness. From a clinical perspective, understanding the nuances of oxandrolone therapy is essential for optimizing patient outcomes in weight gain and tissue repair.
Clinical Benefits and Production of Oxandrolone Steroid
May 20, 26
Clinical Benefits and Production of Oxandrolone Steroid
The global pharmaceutical landscape has seen a significant rise in the demand for highly specialized anabolic agents, among which the oxandrolone steroid stands out due to its unique chemical profile and therapeutic versatility. As a modified version of dihydrotestosterone, this compound provides a potent means of addressing muscle wasting and metabolic deficits, making it a critical asset in both clinical rehabilitation and advanced physiological research. Understanding the nuances of this synthetic compound is essential for healthcare providers and researchers alike, as it balances efficacy with a relatively lower androgenic profile compared to other steroids.

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.